TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Randomized Phase II Study of Nivolumab With or Without Ipilimumab Combined With Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (CheckPAC).

Inna M Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.